Low-dose cyclosporin for Crohn's disease: implications for clinical trials
✍ Scribed by J. BRYNSKOV; V. BINDER; P. RIIS; K. LAURITSEN; O. SCHAFFALITZKY DE MUCKADELL; L. FREUND; J. FALLINGBORG; S. NØRBY RASMUSSEN; P. MATZEN; E. KRAG; U. TAGE-JENSEN; S. JARNUMS
- Book ID
- 108602862
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 415 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0269-2813
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The article by Glode et al. in this issue reports on the empiric success, as defined by a decreased prostate specific antigen level and lack of toxicity, of metronomically delivered low‐dose chemotherapy for patients with hormone‐refractory prostate carcinoma. The data presented were collected as a
## Abstract We provide further validation of a Parkinson's disease (PD) home diary and explore implications for practical use in clinical trials. We previously developed and published a home PD diary that includes the categories ASLEEP, __off__, __on__ without dyskinesia, __on__ with nontroublesome